Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_assertion description "[a significant association was observed between the MTHFR haplotype (single nucleotide polymorphisms 677 and 1298) and risk of developing therapy-related-MDS/AML in the breast cancer patients group and cyclophosphamide-treated hematological disease group ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_assertion evidence source_evidence_literature NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_assertion SIO_000772 17476281 NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_assertion wasDerivedFrom lhgdn-20090331 NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_assertion wasGeneratedBy ECO_0000203 NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP224853.RA92YHqGb7pEMOaNMGp1teDr9B0MZkLgPTtS4aIh3Q8C8130_provenance.